Choosing the right affinity ligand is the key to success in cell and tissue applications—especially for effective cell targeting and reliable biomarker discovery. Lack of reagent compatibility with cell and tissue-based applications can limit your science.

Find out how Optimer discovery uses cell and tissue screens to:

• Derisk the discovery process: Ensure your Optimer binds to the target in your cell targeting applications.
• Deliver the highest performance binders: Include live or fixed samples during discovery to optimize cell targeting.
• Reveal new biomarkers: Utilize cell phenotype directed screens to advance biomarker discovery.
• Overcome protein target supply issues: Leverage Optimer cell screens for robust cell targeting results.

Download the application note to learn more about the Optimer cell discovery process and see the data from both target-directed and phenotype-directed applications. Explore enhanced IHC reagents, targeted delivery of oligonucleotide therapies, and new flow cytometry reagents designed to improve our understanding of cancer biology.

Tags